DE602006020838D1 - Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikum - Google Patents
Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikumInfo
- Publication number
- DE602006020838D1 DE602006020838D1 DE602006020838T DE602006020838T DE602006020838D1 DE 602006020838 D1 DE602006020838 D1 DE 602006020838D1 DE 602006020838 T DE602006020838 T DE 602006020838T DE 602006020838 T DE602006020838 T DE 602006020838T DE 602006020838 D1 DE602006020838 D1 DE 602006020838D1
- Authority
- DE
- Germany
- Prior art keywords
- medicaments
- heart failure
- anticholinergicum
- preventing
- treating heart
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64801205P | 2005-01-28 | 2005-01-28 | |
| PCT/EP2006/050408 WO2006079625A2 (en) | 2005-01-28 | 2006-01-24 | Medicaments for the prevention or treatment of heart failure comprising administration of an anticholinergic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602006020838D1 true DE602006020838D1 (de) | 2011-05-05 |
Family
ID=36129748
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602006020838T Active DE602006020838D1 (de) | 2005-01-28 | 2006-01-24 | Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikum |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7923455B2 (de) |
| EP (1) | EP1843764B1 (de) |
| JP (1) | JP2008528547A (de) |
| AT (1) | ATE502637T1 (de) |
| CA (1) | CA2594693A1 (de) |
| DE (1) | DE602006020838D1 (de) |
| ES (1) | ES2362365T3 (de) |
| WO (1) | WO2006079625A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060287347A1 (en) * | 2005-06-21 | 2006-12-21 | Aberg A K G | Methods for treating smooth muscle disorders using trospium |
| US20070004766A1 (en) * | 2005-07-01 | 2007-01-04 | Aberg A K G | Methods for relaxation of smooth muscle contractions using Trospium |
| JP2009504602A (ja) * | 2005-08-08 | 2009-02-05 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | チオトロピウム塩類を投与することを含む心疾患のリスクに対する保護の方法 |
| JO3510B1 (ar) | 2011-03-04 | 2020-07-05 | Heptares Therapeutics Ltd | استخدام جلايكوبيرولات لعلاج عدم انتظام دقات القلب |
| CZ2014188A3 (cs) | 2014-03-26 | 2015-10-07 | Zentiva, K.S. | Nové formy aclidinium chloridu a způsob jejich přípravy |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1397134A2 (de) * | 2001-05-25 | 2004-03-17 | Boehringer Ingelheim Pharma GmbH & Co.KG | Kombination eines dopamin-d2-rezeptor-agonisten mit tiotropium oder derivaten davon zur behandlung obstruktiver atemwegserkrankungen |
| CN1674918A (zh) * | 2002-06-12 | 2005-09-28 | 埃匹吉尼斯医药有限公司 | 利用脱氢表雄酮甾体及抗毒蕈碱药物治疗呼吸道疾病及肺病的组合物、制剂和试剂盒 |
| TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
| US20050239778A1 (en) * | 2004-04-22 | 2005-10-27 | Boehringer Ingelheim International Gmbh | Novel medicament combinations for the treatment of respiratory diseases |
| ATE539754T1 (de) * | 2004-04-22 | 2012-01-15 | Boehringer Ingelheim Int | Arzneinmittelkombinationen enthaltend benzoxazine zur behandlung von atemwegserkrankungen |
-
2006
- 2006-01-13 US US11/332,646 patent/US7923455B2/en active Active
- 2006-01-24 ES ES06704250T patent/ES2362365T3/es active Active
- 2006-01-24 WO PCT/EP2006/050408 patent/WO2006079625A2/en active Application Filing
- 2006-01-24 EP EP06704250A patent/EP1843764B1/de active Active
- 2006-01-24 DE DE602006020838T patent/DE602006020838D1/de active Active
- 2006-01-24 CA CA002594693A patent/CA2594693A1/en not_active Abandoned
- 2006-01-24 JP JP2007552632A patent/JP2008528547A/ja active Pending
- 2006-01-24 AT AT06704250T patent/ATE502637T1/de active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2594693A1 (en) | 2006-08-03 |
| ES2362365T3 (es) | 2011-07-04 |
| US20060173038A1 (en) | 2006-08-03 |
| EP1843764A2 (de) | 2007-10-17 |
| WO2006079625A3 (en) | 2007-07-26 |
| ATE502637T1 (de) | 2011-04-15 |
| US7923455B2 (en) | 2011-04-12 |
| WO2006079625A2 (en) | 2006-08-03 |
| JP2008528547A (ja) | 2008-07-31 |
| EP1843764B1 (de) | 2011-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1111478T1 (el) | Ενδειξη δοσολογιας προγεστερονης στην αντιμετωπιση τραυματικης εγκεφαλικης βλαβης | |
| ATE480255T1 (de) | Zusammensetzungen und verfahren zur kontrolle, prävention und behandlung von essstörungen | |
| ATE399553T1 (de) | Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen | |
| ATE376828T1 (de) | Verwendung von rotigotin zur behandlung und prävention des parkinson-plus-syndroms | |
| WO2004006842A3 (en) | Combinations of drugs for the treatment of neoplasms | |
| EA201000603A1 (ru) | ПРИМЕНЕНИЕ АНТИТЕЛ К TrkB ДЛЯ ЛЕЧЕНИЯ РЕСПИРАТОРНЫХ НАРУШЕНИЙ | |
| WO2006029036A3 (en) | Combination therapy with glatiramer acetate and n-acetylcysteine for the treatment of multiple sclerosis | |
| WO2006098603A3 (en) | Composition comprising isoorientin for suppressing histamine | |
| WO2005070450A8 (de) | Verwendung von niedrig dosiertem erythropoietin zur behandlung von akuter oder chronischer niereninsuffizienz und zur behandlung von wunden | |
| MX2021015352A (es) | Métodos para tratar la enfermedad de fabry en pacientes que tienen insuficiencia renal. | |
| DE602004021847D1 (de) | Verfahren zur prävention und behandlung von diabetes mit neurturin | |
| DE602006020838D1 (de) | Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikum | |
| DE602004031631D1 (de) | Verwendung von betain zur behandlung von claudicatio intermittens | |
| WO2006101910A3 (en) | Peptide compounds and methods of using peptide compounds to treat conditions affecting the cardiac, pulmonary, and nervous systems | |
| EA202193276A1 (ru) | Способы лечения холангиокарциномы | |
| ATE487480T1 (de) | Perhexilin zur behandlung von chronischer herzinsuffizienz | |
| WO2019232203A3 (en) | Methods and compositions to alleviate vascular permeability | |
| ATE451145T1 (de) | Behandlung von krankheiten | |
| ATE268170T1 (de) | Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz | |
| EA202193211A1 (ru) | Лечение синуклеопатий | |
| WO2008016665A3 (en) | Imidazoacridine compounds for treating flt3 -mediated disorders | |
| MX2020001217A (es) | Metodos de tratamiento de sintomas de gastroparesia usando velusetrag. | |
| DE602004016547D1 (de) | 1,4-dihydropyridinverbindungen, pharmazeutische verbindungen, und verfahren zur behandlung von herzkreislauferkrankungen | |
| EP4327869A3 (de) | Verfahren zur behandlung von nierenfunktionsbeeinträchtigten fabry-patienten | |
| EA200702274A1 (ru) | Твёрдые кристаллические и аморфные формы (-)-галофената и способ их получения, фармацевтическая композиция на их основе и способ лечения |